INTERNATIONAL DOWN SYNDROME MEDICAL INTEREST GROUP MEETING At the 11th World Down Syndrome Congress, Cape Town, South Africa Venue: Cape Town International Convention Centre 14 August, 2012 - 1pm to 6pm Provisional Programme Chair: Dr Liz Marder, Consultant Paediatrician, Nottingham University Hospitals, UK and Meetings Convenor, DSMIG (UK and Ireland) 12.00 Registration for those registered on DSMIG meeting and main congress 13.00 Opening address: My appeal to health providers Ms Jaspreet Kaur Sekhon, Self-advocate, Singapore 13.20 Delegate introductions Each delegate to introduce themselves, their interest in Down Syndrome and a brief over view of services in their country 14.30 Service co-ordination for children with Down Syndrome in Cape Town: The Red Cross experience Dr Shetil Nana, Paediatric Registrar & Dr Kirsty Donald, Senior Specialist, Division of Developmental Paediatrics Red Cross Children's Hospital and UCT, South Africa 15.00 DSMIG UK and Ireland – recent activity, new developments to include new PCHR insert and growth charts Dr Marian McGowan, Consultant Paediatrician, St George’s Hospital London and Chairman, DSMIG UK and Ireland 15.15 USA Revision Of Health Care Guidelines For Persons With Down Syndrome Siegfried M.Pueschel MD, PhD, JD, MPH, Professor of Pediatrics Brown University, Providence, RI, USA 15.30 Developing DSMIG International Dr Balbir Singh, Vice Chair, Board of Trustees, Down Syndrome International; Advisor & Founding Chair DSA Singapore & Dr Bhavani Sriram, Medical Advisor, Down Syndrome Association, Singapore Senior Consultant Neonatologist, KK Women's & Children Hospital, Singapore 15.45 Refreshments 16.00 Hot Topic – Cancer in people with Down Syndrome Daniel Satgé MD, PhD, ONCODEFI Project, Epidemiology and Biostatistics, Institut Universitraire de Recherche Clinique, Montpellier, France 16.45 Short Papers: Epidemiological study on skin and hair in a cohort of 90 French persons with Down syndrome Jacqueline London, President of the French Association for Research on Trisomy 21 Professor in Molecular Pathology, Life Sciences Department University Paris-Diderot Corneal Collagen Crosslinking (CXL) and new therapeutic options to treat progressive keratoconus - Farhad Hafezi MD PhD, Professor and Chair of Ophthalmology Department of Clinical Neurosciences University Hospitals of Geneva, Switzerland The positive impact of the Developmental Resource Stimulation Programme on the developmental domains of the child with Down syndrome younger than 42 months Dorothy C Russell, Director: Bloemfontein Child Information Centre Occupational Therapist at Department Paediatric and Child Health University of the Free State, South Africa 17.30 Interesting Cases 18.00 Close